UNICA IRIS Institutional Research Information System

CARPINIELLO, BERNARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 369.011
NA - Nord America 34.130
AS - Asia 18.333
SA - Sud America 3.114
Continente sconosciuto - Info sul continente non disponibili 1.256
AF - Africa 463
OC - Oceania 106
Totale 426.413
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 353.678
US - Stati Uniti d'America 33.334
SG - Singapore 6.908
CN - Cina 6.435
UA - Ucraina 4.017
NL - Olanda 3.204
BR - Brasile 2.477
SE - Svezia 2.258
VN - Vietnam 1.575
FI - Finlandia 1.420
FR - Francia 1.195
DE - Germania 1.182
GB - Regno Unito 1.152
HK - Hong Kong 887
CA - Canada 512
IN - India 475
KR - Corea 455
BD - Bangladesh 346
AR - Argentina 216
RU - Federazione Russa 188
IQ - Iraq 158
JP - Giappone 134
TR - Turchia 134
MX - Messico 126
ID - Indonesia 123
EC - Ecuador 115
ZA - Sudafrica 108
ES - Italia 99
AU - Australia 95
PK - Pakistan 95
PL - Polonia 89
PH - Filippine 85
CO - Colombia 84
MA - Marocco 70
VE - Venezuela 65
EG - Egitto 64
SA - Arabia Saudita 61
IE - Irlanda 59
UZ - Uzbekistan 58
IR - Iran 57
CH - Svizzera 56
BE - Belgio 54
KE - Kenya 50
AT - Austria 48
CL - Cile 48
RO - Romania 47
JM - Giamaica 45
MY - Malesia 45
PY - Paraguay 41
NO - Norvegia 31
DZ - Algeria 30
IL - Israele 30
JO - Giordania 30
AE - Emirati Arabi Uniti 26
PE - Perù 26
TH - Thailandia 26
TN - Tunisia 24
AZ - Azerbaigian 23
ET - Etiopia 23
BO - Bolivia 22
CZ - Repubblica Ceca 22
DK - Danimarca 22
NP - Nepal 22
CR - Costa Rica 19
LT - Lituania 19
PT - Portogallo 19
LB - Libano 18
UY - Uruguay 18
GR - Grecia 16
HU - Ungheria 16
KZ - Kazakistan 16
SN - Senegal 16
TW - Taiwan 16
BG - Bulgaria 15
GT - Guatemala 15
HN - Honduras 15
HR - Croazia 15
MU - Mauritius 15
SK - Slovacchia (Repubblica Slovacca) 15
NG - Nigeria 14
EU - Europa 13
NI - Nicaragua 13
PS - Palestinian Territory 13
DO - Repubblica Dominicana 12
OM - Oman 12
NZ - Nuova Zelanda 11
RS - Serbia 11
AL - Albania 10
PA - Panama 10
EE - Estonia 9
LV - Lettonia 9
QA - Qatar 9
TT - Trinidad e Tobago 9
AO - Angola 8
BH - Bahrain 8
GH - Ghana 7
KG - Kirghizistan 7
KW - Kuwait 7
MD - Moldavia 7
AM - Armenia 6
Totale 425.052
Salva come PNG Salva come JPEG
Città #
Cagliari 338.861
Uta 8.242
Singapore 3.320
Amsterdam 2.985
Chandler 2.617
Ashburn 2.400
San Jose 2.257
Boardman 2.255
Jacksonville 2.151
Dallas 2.094
Fairfield 1.867
Woodbridge 1.580
Ann Arbor 1.266
Wilmington 1.053
Houston 1.026
Nyköping 966
Beijing 962
Helsinki 797
Hong Kong 794
Los Angeles 771
Hefei 767
Boston 717
Seattle 704
Council Bluffs 657
Nanjing 640
Milan 608
Lauterbourg 602
Cambridge 579
Ho Chi Minh City 506
Rome 504
Seoul 430
Buffalo 425
New York 358
Hanoi 339
Santa Clara 324
The Dalles 310
Toronto 259
Dearborn 252
Shanghai 232
São Paulo 212
Shenyang 206
Tianjin 186
Nanchang 171
Verona 165
Changsha 163
San Diego 162
Hebei 147
Chicago 146
Guangzhou 145
Jiaxing 139
Orem 128
Redwood City 125
Frankfurt am Main 120
Dong Ket 114
Norwalk 113
Orange 104
Brooklyn 90
Naples 89
Tokyo 89
Washington 89
Jinan 88
London 88
Bologna 85
Zhengzhou 85
Munich 83
Phoenix 83
Columbus 81
Redondo Beach 79
Florence 77
Rio de Janeiro 76
Haiphong 75
Atlanta 73
Chennai 71
Turin 70
Warsaw 68
Montreal 67
Ningbo 65
Nuremberg 60
Cardiff 58
Sassari 58
Bari 57
Johannesburg 56
Pune 55
Da Nang 54
Hangzhou 54
Nieuwegein 54
Saint Petersburg 54
Baghdad 52
Belo Horizonte 52
San Francisco 47
Tashkent 47
Denver 46
Brussels 43
Nairobi 43
Dublin 42
Mountain View 42
Padova 42
Porto Alegre 41
Redmond 41
Brasília 40
Totale 392.832
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.679
Violence and mental disorders. A retrospective study of people in charge of a community mental health center 4.484
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia 4.260
Validation of the italian version of the compensatory eating and behaviors in response to alcohol consumption scale (CEBRACS) 4.245
Mental disorders in obese patients with and without metabolic syndrome 3.941
Psychopathology, psychosocial factors and obesity 3.849
The asthma-anxiety connection 3.726
Obesità, sindrome metabolica e comorbidità psichiatriche 3.710
Obesità e qualità della vita 3.685
Le psicoterapie 3.685
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 3.676
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 3.645
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 3.641
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.516
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.433
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.430
Duration of untreated illness as a key to early intervention in schizophrenia: A review 3.181
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.156
Obesity, alexithymia and psychopathology: A case-control study 3.121
Mental disorders in patients with metabolic syndrome. The key role of central obesity 3.030
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.022
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.896
Il modello alternativo del DSM-5 per i disturbi di personalità 2.735
Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders 2.682
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.682
Obesità e psicopatologia 2.674
Obesità, sindrome metabolica e comorbidità psichiatriche 2.661
Obesità e psicopatologia 2.646
Obesità, sindrome metabolica e comorbidità psichiatriche 2.606
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.602
Biomarkers in aggression 2.548
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.517
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 2.494
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 2.414
Obesità e alessitimia 2.410
Obesità e comorbidità psichiatrica di Asse I: risultati di uno studio caso – controllo 2.386
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.361
Diagnostic reliability in schizoaffective disorder 2.301
Disturbi da uso di sostanze e malattie dentali: lo stato dell’arte 2.178
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia 2.042
Obesità e alessitimia 2.038
Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study 2.004
Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report 2.002
Obesità, alessitimia e rappresentazione corporea: risultati di uno studio caso – controllo 1.999
Mental health in transgender individuals: a systematic review 1.946
Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit 1.934
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.928
Unblending borderline personality and bipolar disorders 1.904
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.892
Clinicians’ attitudes to cardiac function monitoring guidelines during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness 1.881
Obesità e punteggi all’SCL-90-R 1.846
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets 1.837
PALIPERIDONE PALMITATE IN ACUTE PATIENTS WITH SCHIZOPHRENIA - TREATMENT RESPONSE, SAFETY AND TOLERABILITY: A PROSPECTIVE FLEXIBLE DOSE STUDY IN PATIENTS PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS 1.836
Disturbi dell'Umore 1.807
Asthma and psychiatric disorders 1.799
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 1.685
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.681
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.664
Obesità e comorbidità psichiatrica di asse I: studio caso - controllo 1.663
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study 1.642
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.641
First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services 1.625
Differenze di genere nella remissione e recovery di pazienti schizofrenici e schizoaffettivi: risultati di uno studio di coorte prospettico 1.622
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 1.614
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.603
The Italian version of the borderline personality disorder severity index IV: Psychometric properties, clinical usefulness, and possible diagnostic implications 1.594
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.590
Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder 1.573
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.559
Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions 1.551
Il disturbo bipolare e la comorbidità con i disturbi di personalità 1.516
Accuracy of self-assessment of real-life functioning in schizophrenia 1.506
Approccio al trattamento dell’obesità: 5 anni di esperienza in un team multidisciplinare metabolico - psicoeducazionale – motorio 1.489
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 1.478
Personalized psychiatry: Promises and pitfalls 1.477
How Is the History of Early Traumatic Exposure Associated With the Psychopathological Outcomes of COVID-19 Related Lockdown and Subsequent Re-opening in People With Eating Disorders? 1.468
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia 1.462
Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study 1.457
Disturbo da sintomi somatici e disturbi correlati 1.456
Obesità e disturbi d’ansia 1.443
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy 1.442
Obesità e ansia 1.426
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 1.415
Schizofrenia e disturbo schizoaffettivo: differenze cliniche, di decorso, esito e trattamento 1.413
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics 1.387
Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: A retrospective report on 434 patients with severe mental illness 1.375
Obesità e qualità della vita 1.363
Obesità e disturbi di personalità 1.360
The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future 1.351
Disturbi della nutrizione e dell'alimentazione 1.351
Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology 1.349
The reciprocal relationship between suicidality and stigma 1.313
Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets 1.311
Obesità e disturbi di personalità: risultati di uno studio caso - controllo 1.294
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia 1.285
Prevalence and clinical correlates of cognitive symptoms in depression: A naturalistic study 1.277
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.276
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.269
Obesità e disturbi di personalità 1.217
Le cure 1.214
Totale 221.350
Salva come PNG Salva come JPEG
Categoria #
all - tutte 654.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 654.931
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218.365 0 1.744 1.090 1.523 1.842 1.450 973 905 1.419 1.601 2.815 3.003
2022/202333.545 2.927 2.859 2.970 2.628 2.664 3.452 1.397 6.784 2.294 1.687 2.351 1.532
2023/202444.625 2.576 1.506 2.647 4.157 3.964 7.633 6.465 3.063 2.217 3.347 3.666 3.384
2024/2025107.212 32.267 30.919 9.842 7.522 4.336 4.334 10.309 775 1.515 2.258 1.393 1.742
2025/202634.288 1.896 1.525 4.893 3.559 2.116 2.243 5.445 1.932 4.045 2.910 2.498 1.226
2026/20271.246 396 850 0 0 0 0 0 0 0 0 0 0
Totale 426.413